UKM Medical Molecular Biology Institute (UMBI), Kuala Lumpur, Cheras, Malaysia.
Int J Lab Hematol. 2012 Aug;34(4):377-82. doi: 10.1111/j.1751-553X.2012.01405.x. Epub 2012 Feb 15.
To study the ß-gene mutations spectrum, the genotype/phenotype correlation, the modulatory effect of co-inherited factors such as α-gene mutations and of Xmn1 polymorphism in a large cohort of Malaysian patients.
A total of 264 cases clinically diagnosed as Thalassemia major (TM) (111), Thalassemia intermedia (21), HbE-β Thalassemia (131), and 1 HbE homozygous were studied. The detection of α and ß gene mutations and characterization of Xmn1 polymorphism were performed by multiplex PCR, amplification refractory mutation system (ARMS), DNA sequencing, and restriction fragment length polymorphism (RFLP)-PCR.
A total of 19 ß Thalassemia mutations were characterized. CD26 and CD41/42 were the most common found in the Malay and Chinese population, respectively. The sensitivity of the clinical diagnosis for β TM, thalassemia intermedia, and HbE/β thalassemia was 94.0%, 15.2%, and 89.2%, respectively. Patients with Xmn1 heterozygosity [+/-] required less frequent transfusion compared with those without the polymorphism. Co-inheritance of α-thalassemia alleviates the severity of HbE-β thalassemia in our cohort.
Molecular analysis should be used for a better diagnosis and management of β thalassemia.
为了研究β-珠蛋白基因突变谱、基因型/表型相关性,以及在马来西亚患者的大样本中,共同遗传因素(如α-基因突变和 Xmn1 多态性)的调节作用。
共研究了 264 例临床诊断为重型β地中海贫血(TM)(111 例)、中间型β地中海贫血(21 例)、HbE-β 地中海贫血(131 例)和 1 例 HbE 纯合子患者。采用多重 PCR、扩增受阻突变系统(ARMS)、DNA 测序和限制性片段长度多态性(RFLP)-PCR 检测α和β基因的突变,并对 Xmn1 多态性进行了特征分析。
共鉴定了 19 种β地中海贫血突变。CD26 和 CD41/42 分别是马来人和华人中最常见的突变。β TM、中间型地中海贫血和 HbE/β 地中海贫血的临床诊断灵敏度分别为 94.0%、15.2%和 89.2%。Xmn1 杂合子(+/-)的患者与没有多态性的患者相比,需要的输血频率更低。在我们的研究队列中,共同遗传的α-地中海贫血减轻了 HbE-β 地中海贫血的严重程度。
分子分析应用于更好地诊断和管理β地中海贫血。